CLINICAL_TRIALS
trial_result
· 2016-10-21
Clinical Trial Update: Special Investigation For Gist Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan).
Summary
Clinical trial update for a post-marketing commitment study of sunitinib malate in gastrointestinal stromal tumors has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Gastrointestinal Stromal Tumors | Status: COMPLETED | Results posted: 2016-10-21